PwC Switzerland, the well-known audit and advisory firm in Switzerland, has acquired Avoras Holding as part of its growth strategy in the consulting area. The Swiss firm specialising in SAP business transformation consultancy in the pharma and life sciences sector, has grown to 60 employees and serves customers worldwide. In addition to its headquarters in Basel, Avoras […]
BlackSheep MadTech Fund, managed by EUREKA! Venture SGR, the first European venture capital fund with an entrepreneurial background that invests in the marketing and advertising technology industry, has been the lead investor in the USD 5
Medartis, a Basel-based orthopedic company specializing in head and extremity surgery, recently signed an agreement with the private founders of KeriMedical, a Geneva-based private company specializing in the development and manufacture of implants for hand
Kellerhals Carrard advised UNISERS, a Swiss semiconductor metrology company that identifies invisible defects caused by contamination in semiconductor materials, which raised $14 million in seed funding. The deal was led by Intel Capital, with participation from
Relai, a Switzerland-based Bitcoin-only investment platform, announced the closing of a USD 4.5 million financing. The round was led by ego death capital (EDC), with further participation from Timechain, Cabrit Capital and Lightning Ventures, as well
As we have informed here, the private equity firm Argos Wityu has acquisted a majority stake in Norline, a leading provider of outsourcing services in the heating, ventilation, air conditioning and plumbing sector in Switzerland.
Oculis Holding, a global biopharmaceutical company, purposefully driven to save sight and improve eye care, listed its shares on Nasdaq after successfully closing the business combination between European Biotech Acquisition Corp. (“EBAC”). At closing, Oculis
CODE41, a community-centric Swiss watchmaking company, has increased its share capital by issuing participation certificates in the form of ledger-based securities, thanks to the tokenisation technology of Taurus and the opensource smart contract published by
The European Investment Bank (EIB) and GeNeuro, a French biopharmaceutical company, has entered through its R&D subsidiary, GeNeuro Innovation, into a financing agreement for a total amount of up to EUR 25 million. The
Niederer Kraft Frey has advised Bearmind as Swiss counsel on its seed financing round led by HH Equity Partners II. The EPFL spinoff has secured CHF 1.3 million in the seed round that also included participation
